• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1例经新辅助卡培他滨、奥沙利铂、贝伐单抗及放疗成功治疗的局部浸润性直肠癌切除病例]

[A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].

作者信息

Suzuki Shunji, Shigaki Nobuyuki, Yokoyama Sachio, Yamashita Hiroya, Sugita Hiroki, Arima Nobuyuki

机构信息

Dept. of Surgery, Kumamoto Municipal Hospital.

出版信息

Gan To Kagaku Ryoho. 2011 Sep;38(9):1545-7.

PMID:21918360
Abstract

A 57-year-old man was admitted to our hospital with a complaint of perineal pain. He was diagnosed as advanced rectal cancer with an invasion of prostate, and we conducted neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy. After chemoradiation therapy, the tumor regressed to an ulcerative lesion without invasion of the prostate. Abdominoperineal resection was then performed without radical resection. The tumor regressed to an ulcer and only a few cancer cells were detected in the submucosal layer pathologically.

摘要

一名57岁男性因会阴部疼痛入院。他被诊断为晚期直肠癌伴前列腺侵犯,我们对其进行了新辅助卡培他滨、奥沙利铂、贝伐单抗和放射治疗。放化疗后,肿瘤退缩为溃疡性病变,无前列腺侵犯。随后进行了腹会阴切除术,但未进行根治性切除。肿瘤退缩为溃疡,病理检查在黏膜下层仅检测到少数癌细胞。

相似文献

1
[A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].[1例经新辅助卡培他滨、奥沙利铂、贝伐单抗及放疗成功治疗的局部浸润性直肠癌切除病例]
Gan To Kagaku Ryoho. 2011 Sep;38(9):1545-7.
2
Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.XELOX 方案联合贝伐珠单抗新辅助化疗治疗局部高危进展期直肠癌
Cancer Chemother Pharmacol. 2014 May;73(5):1079-87. doi: 10.1007/s00280-014-2417-9. Epub 2014 Mar 5.
3
[A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].[新辅助化疗联合奥沙利铂、氟尿嘧啶和贝伐单抗治疗局部晚期直肠癌获病理完全缓解1例报告]
Gan To Kagaku Ryoho. 2012 Jun;39(6):1001-3.
4
Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial.新辅助奥沙利铂和卡培他滨联合贝伐珠单抗治疗低危直肠癌:N-SOG 03 期 II 期试验。
Jpn J Clin Oncol. 2013 Oct;43(10):964-71. doi: 10.1093/jjco/hyt115. Epub 2013 Aug 9.
5
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.局部晚期直肠癌新辅助贝伐珠单抗、卡培他滨和放疗的 II 期临床试验。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):824-30. doi: 10.1016/j.ijrobp.2009.02.037. Epub 2009 May 21.
6
Neoadjuvant chemoradiation for rectal cancer: is more better?直肠癌的新辅助放化疗:越多越好吗?
Oncology (Williston Park). 2008 Jun;22(7):814-26; discussion 826, 828-31, 836.
7
Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results.贝伐单抗、奥沙利铂和卡培他滨联合放疗用于直肠癌:I期试验结果。
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):472-8. doi: 10.1016/j.ijrobp.2007.02.001.
8
Combined-modality therapy for rectal cancer: future prospects.直肠癌的综合治疗:未来前景
Clin Colorectal Cancer. 2007 Sep;6(9):625-33. doi: 10.3816/CCC.2007.n.030.
9
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.直肠癌患者新辅助5-氟尿嘧啶或卡培他滨联合放疗加或不加奥沙利铂:一项III期随机临床试验
J Natl Cancer Inst. 2015 Sep 14;107(11). doi: 10.1093/jnci/djv248. Print 2015 Nov.
10
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.术前贝伐珠单抗、卡培他滨、奥沙利铂和放疗治疗局部晚期或低位直肠癌患者:一项 II 期试验。
Eur J Cancer. 2012 Jan;48(1):37-45. doi: 10.1016/j.ejca.2011.05.016. Epub 2011 Jun 12.